your market intelligence analyst
Search Results
11 results
Your search is now limited to «Chemotherapy» expert search.
Your search is now limited to only one Source. To return to results from all sources click here. 02/24/2020 09:55
In addition, a phase III trial of Optune® (200 kHz) as monotherapy compared to active chemotherapy in recurrent glioblastoma patients showed TTFields to be equivalent to active chemotherapy in extending survival, associated with minimal toxicity, good quality of life, and activity within the brain (14% response rate. 02/24/2020 08:55
Conditions : Recurrent Head and Neck Squamous Cell Carcinoma; Head and Neck Cancer Stage IV Interventions : Drug: Nivolumab + Paclitaxel; Drug: Cetuximab + Paclitaxel Sponsors : Grupo Español de Tratamiento de Tumores de Cabeza y Cuello; Bristol-Myers Squibb; Apices Soluciones S.L. Not yet recruiting. 02/19/2020 12:00
Patients will then receive hepatic artery infusion floxuridine as well as disease-appropriate systemic chemotherapy (FOLFOX, FOLRIRI, or oxaliplatin/irinotecan) Device: Hepatic artery infusion pump placement using the Synchromed II pump and the Codman tapered arterial catheter.

Financial Services

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Political Entities


Strategic Scenarios



  • Actions
    • Bookmark and Share: Allows you to Bookmark the page for easy future retrieval and sharing with colleagues
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • Previous Versions: Only shown if essentially the same document has been republished
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Save" button to the right of the search box. 

Click here for more info on Search Results.